Cite
Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment.
MLA
Cao, Yu, et al. “Metabolism Guided Optimization of Peptidomimetics as Non-Covalent Proteasome Inhibitors for Cancer Treatment.” European Journal of Medicinal Chemistry, vol. 233, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2022.114211.
APA
Cao, Y., Tu, Y., Fu, L., Yu, Q., Gao, L., Zhang, M., Zeng, L., Zhang, C., Shao, J., Zhu, H., Zhou, Y., Li, J., & Zhang, J. (2022). Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment. European Journal of Medicinal Chemistry, 233, N.PAG. https://doi.org/10.1016/j.ejmech.2022.114211
Chicago
Cao, Yu, Yutong Tu, Liping Fu, Qian Yu, Lixin Gao, Mengmeng Zhang, Linghui Zeng, et al. 2022. “Metabolism Guided Optimization of Peptidomimetics as Non-Covalent Proteasome Inhibitors for Cancer Treatment.” European Journal of Medicinal Chemistry 233 (April): N.PAG. doi:10.1016/j.ejmech.2022.114211.